Auriculotherapy in the Treatment of Dysmenorrhea

University of Sorocaba74 enrolled

Overview

This study aims to determine if auriculotherapy is effective in the treatment of dysmenorrhoea. This intervention consists of fixation of yellow mustard seeds at specific points of the auricular pavilion (or area), with opaque tape. Half of the participants will have specific ear pinch points stimulated by mustard seeds fixed with opaque plaster, while the other half will have only the adhesive plasters fixed, without the seeds for stimulation.

Primary dysmenorrhoea is responsible for the most part of dissatisfactions in the female class, in the face of discomforts which are caused monthly. For this, the income index of this woman in the work environment tends to reduce, thus harming the development of every sector to which she responds. The expected effects, after the intervention, will be positive, favoring a considerable improvement of the symptoms reported by the women. We chose auriculotherapy because it is a non-medicated, noninvasive intervention that is inexpensive.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Primary Dysmenorrhea

Interventions

auriculotherapyDEVICE

The participants will be submitted to a session per week with duration of 20 minutes, for three consecutive months, to fix the adhesives. The points selected for stimulation, according to Chinese atrial mapping, are: uterus, endocrine, ovary, pituitary, shen men, sympathetic, and liver. Participants will be advised to remain with the stickers fixed to the auricle for six days.

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * To be eligible to participate in this study, the individual must meet the following criteria: * Free and informed consent form, duly signed and dated * Consent to voluntarily participate in all study procedures and availability for the duration of the study * Female subjects * Age above of 18 years old * Enjoy good general health * Have active menstrual cycle * Complaint about dysmenorrhea Exclusion Criteria: * An individual who meets any of the following criteria will be excluded from participation in this study: * Clinical diagnosis of endometriosis * Myomas * Pelvic inflammatory disease * Adenomyosis * In the active phase for treatment of cancer (chemotherapy or radiotherapy) * Women who are already in menopause * Pregnancy

Locations (1)

Universidade de Sorocaba - Campus Cidade Universitária

Sorocaba, São Paulo, Brazil

Outcomes

Primary Outcomes

Measurement on pain perception

The numerical visual scale of pain 0-10 (0 = no pain, 10 = worst possible pain), applied at the beginning of the intervention period and reapplied to each menstrual period during the 12 weeks of follow-up will be used.

Time frame: 12 weeks

Secondary Outcomes

Welfare

The quality of life questionnaire (Short-Form Health Survey SF36) will be applied at the beginning of the intervention period and reapplied at the end of the 12 weeks of intervention.

Time frame: 12 weeks

Number of participants with adverse events

Adverse events will be collected spontaneously by the active survey, at all visits of participants.

Time frame: 12 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.